HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian-Yong Li Selected Research

Decitabine

6/2023[Efficacy and Safety of Decitabine Combined with Modified CAG Regimen in Patients Aged ≥ 70 Years with Newly Diagnosed Acute Myeloid Leukemia].
12/2020Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation.
2/2020Decitabine as a treatment choice for de novo acute basophilic leukemia: transient response-a case report.
1/2020Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian-Yong Li Research Topics

Disease

50B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 06/2006
27Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2023 - 06/2004
22Neoplasms (Cancer)
04/2024 - 08/2006
22Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 08/2008
19Lymphoma (Lymphomas)
04/2024 - 04/2003
17Leukemia
04/2024 - 04/2003
16Multiple Myeloma
04/2024 - 02/2006
16Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 10/2006
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2024 - 11/2010
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 06/2006
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 07/2006
8Hematologic Neoplasms (Hematological Malignancy)
04/2024 - 04/2006
7B-Cell Lymphoma (Lymphoma, B Cell)
05/2016 - 04/2006
6Infections
04/2024 - 05/2013
6Anemia
03/2023 - 06/2013
6Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2020 - 04/2006
5Hyperlipidemias (Hyperlipidemia)
03/2024 - 08/2015
5Inflammation (Inflammations)
11/2023 - 08/2015
5Thrombosis (Thrombus)
01/2023 - 04/2008
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 08/2015
5Residual Neoplasm
08/2021 - 06/2006
5Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
04/2013 - 12/2010
4Disease Progression
11/2023 - 12/2019
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2023 - 01/2019
4Fever (Fevers)
06/2023 - 08/2015
4Hemorrhage
01/2023 - 04/2008
4Acute Promyelocytic Leukemia
01/2021 - 11/2013
4Philadelphia Chromosome
01/2020 - 08/2006
4Pain (Aches)
06/2019 - 12/2012
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2019 - 04/2003
4Large Granular Lymphocytic Leukemia
10/2017 - 03/2014
3Euthyroid Sick Syndromes (Euthyroid Sick Syndrome)
04/2023 - 01/2017
3Diarrhea
01/2022 - 12/2012
3Extranodal NK-T-Cell Lymphoma
02/2021 - 02/2015
3Hodgkin Disease (Hodgkin's Disease)
01/2021 - 01/2016
3Splenomegaly
10/2019 - 04/2008
3Pancytopenia
10/2017 - 08/2009
3Lymphocytosis
10/2017 - 09/2012
3Thymus Hyperplasia
05/2016 - 01/2015
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2013 - 07/2006
3Carcinogenesis
06/2013 - 10/2010
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
04/2024 - 01/2018
2Epstein-Barr Virus Infections
01/2024 - 03/2016
2Aplastic Anemia (Anemia, Hypoplastic)
08/2023 - 12/2010
2Intestinal Diseases (Diseases, Intestinal)
06/2023 - 01/2022
2Acute Lung Injury
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
03/2024 - 06/2006
15MicroRNAs (MicroRNA)IBA
04/2024 - 04/2006
15Messenger RNA (mRNA)IBA
10/2018 - 04/2003
13Rituximab (Mabthera)FDA Link
04/2023 - 04/2007
13L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2019 - 12/2007
11fludarabineIBA
01/2014 - 07/2008
10DNA (Deoxyribonucleic Acid)IBA
09/2023 - 04/2007
9aspirin eugenol esterIBA
01/2022 - 01/2015
9Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2020 - 04/2003
9Cytarabine (Cytosar-U)FDA LinkGeneric
12/2020 - 10/2007
8Biomarkers (Surrogate Marker)IBA
03/2023 - 08/2009
8Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
06/2021 - 07/2009
7Bortezomib (Velcade)FDA Link
10/2019 - 02/2006
7AntigensIBA
07/2016 - 07/2006
5LipidsIBA
04/2024 - 08/2015
5EnzymesIBA
03/2024 - 04/2012
5Vitamin DFDA LinkGeneric
11/2023 - 04/2020
5Immunoglobulins (Immunoglobulin)IBA
10/2021 - 10/2009
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2019 - 07/2012
5Imatinib Mesylate (Gleevec)FDA Link
04/2018 - 03/2011
5Monoclonal AntibodiesIBA
11/2013 - 10/2006
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2023 - 01/2013
4Indicators and Reagents (Reagents)IBA
09/2023 - 12/2010
4DecitabineFDA Link
06/2023 - 01/2020
4Therapeutic UsesIBA
01/2022 - 04/2007
4CholesterolIBA
01/2022 - 08/2015
4CytokinesIBA
01/2022 - 02/2006
4C-Reactive ProteinIBA
04/2021 - 06/2015
4AclarubicinIBA
12/2020 - 10/2007
4RNA (Ribonucleic Acid)IBA
04/2019 - 06/2010
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 07/2008
4Hemoglobins (Hemoglobin)IBA
06/2015 - 04/2008
4Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2014 - 01/2009
3Apolipoproteins E (ApoE)IBA
03/2024 - 01/2022
3oxidized low density lipoproteinIBA
03/2024 - 08/2015
3ibrutinibIBA
01/2022 - 02/2014
3Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 02/2014
3Arsenic Trioxide (Trisenox)FDA Link
01/2021 - 11/2013
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 08/2008
3ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)IBA
06/2012 - 07/2009
3Proteasome InhibitorsIBA
10/2011 - 02/2006
2Bile Acids and Salts (Bile Acids)IBA
03/2024 - 01/2022
2pegaspargase (Oncaspar)FDA Link
03/2023 - 01/2019
2SphingolipidsIBA
01/2022 - 10/2017
2Glycerophospholipids (Phosphoglycerides)IBA
01/2022 - 10/2017

Therapy/Procedure

36Therapeutics
01/2022 - 06/2004
15Drug Therapy (Chemotherapy)
01/2024 - 06/2008
4Hematopoietic Stem Cell Transplantation
08/2023 - 06/2006
3CAG protocol
06/2023 - 10/2007
3Transplantation
10/2017 - 12/2008
3Aftercare (After-Treatment)
05/2011 - 06/2009
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2009 - 10/2008
2Time-to-Treatment
11/2023 - 03/2016
2Splenectomy
03/2023 - 09/2011